{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:42:08Z","timestamp":1740159728733,"version":"3.37.3"},"reference-count":64,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hospital Practice"],"published-print":{"date-parts":[[2023,8,8]]},"DOI":"10.1080\/21548331.2023.2266019","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:03:41Z","timestamp":1699261421000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Management of breast cancer patients with\n            <i>BRCA<\/i>\n            gene mutations in Jordan: perspectives and challenges"],"prefix":"10.1080","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-6051","authenticated-orcid":false,"given":"Hikmat","family":"Abdel-Razeq","sequence":"first","affiliation":[{"name":"Deputy Director General, Chief Medical Officer, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Abbasi","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology; Associate Professor of Medicine, Hematology &amp; Oncology, Private Sector, Jordan University, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghadeer","family":"Abdeen","sequence":"additional","affiliation":[{"name":"Consultant Internal Medicine and Medical Oncologist, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-8625","authenticated-orcid":false,"given":"Hazem","family":"Abdulelah","sequence":"additional","affiliation":[{"name":"Consultant Internal Medicine and Medical Oncologist, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Debs","sequence":"additional","affiliation":[{"name":"Medical Affairs, Pfizer Inc., Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Al Masri","sequence":"additional","affiliation":[{"name":"Medical Affairs, Pfizer Inc., Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdi H.","family":"Aljadayeh","sequence":"additional","affiliation":[{"name":"Head of Medical Oncology, Hematology and Stem Cell Transplant Unit, Military Cancer Center, Royal Medical Services, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-948X","authenticated-orcid":false,"given":"Abdalla","family":"Awidi","sequence":"additional","affiliation":[{"name":"Professor of Medicine, Hematology &amp; Oncology, Director of cell therapy center, Chief of Hematology &amp; Oncology, Cell Therapy center, The University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_4_3_1","unstructured":"Ministry Of Health. Jordan Cancer Registry Cancer Incidence In Jordan 2018 [Internet]. 2018 [cited 2023 May 24]. Available from: https:\/\/moh.gov.jo\/ebv4.0\/root_storage\/ar\/eb_list_page\/\u0627\u0644\u062a\u0642\u0631\u064a\u0631_\u0627\u0644\u0633\u0646\u0648\u064a_\u0644\u0627\u0635\u0627\u0628\u0627\u062a_\u0627\u0644\u0633\u0631\u0637\u0627\u0646_\u0627\u0644\u0645\u0633\u062c\u0644\u0629_\u0641\u064a_\u0627\u0644\u0627\u0631\u062f\u0646_\u0644\u0639\u0627\u0645_2018.pdf"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00279"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju055"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100531"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S206949"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-018-0046-7"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02893449"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO20193715_suppl1048"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12158"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4029-y"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9645147"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.18.00066"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3323"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94403-1"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74250-2"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.673094"},{"key":"e_1_3_4_19_1","unstructured":"NCCN. NCCN clinical practice guidelines in Oncology (NCCN guidelines \u00ae) breast cancer version 4.2023 [Internet]. 2023 [cited 2023 May 24]. Available from: https:\/\/www.nccn."},{"key":"e_1_3_4_20_1","unstructured":"Dwyer M NCCN clinical practice guidelines in Oncology (NCCN guidelines \u00ae) genetic\/familial high-risk assessment: breast ovarian and pancreatic. 2023 [cited 2022 Sep 21]. Available from: https:\/\/www.nccn.org\/home\/member-"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-7945-2_22"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5463-1"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4635-4"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01349-9"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07549-8"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12595-w"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51906"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-1986-2"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01631"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06376-4"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37428"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06622-3"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.11.023"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3619"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-021-00191-0"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071929"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2021.1859372"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090847"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002748.pub4"},{"issue":"4","key":"e_1_3_4_40_1","first-page":"585","article-title":"Association of risk-reducing salpingo-oophorectomy with breast cancer risk in women with BRCA1 and BRCA2 pathogenic variants","volume":"7","author":"Choi YH","year":"2021","unstructured":"Choi YH, Terry MB, Daly MB, et al. Association of risk-reducing salpingo-oophorectomy with breast cancer risk in women with BRCA1 and BRCA2 pathogenic variants. JAMA Oncol. 2021 Apr 1 [cited 2022 Sep 21];7(4):585\u2013592. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33630024\/.","journal-title":"JAMA Oncol"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012464.pub2"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1465"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-021-01312-2"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2019.07.014"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.02.001"},{"key":"e_1_3_4_46_1","unstructured":"Rashmi Kumar N Berardi R Abraham J et al. NCCN guidelines version 4.2022 breast cancer. 2022 [cited 2022 Sep 21]. Available from: https:\/\/www.nccn1."},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01779"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012191.pub2"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz012"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802905"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2098"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202152"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.11.018"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30447-2"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S369844"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011395.pub2"},{"key":"e_1_3_4_58_1","first-page":"40","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer","author":"Geyer CE","year":"2022","unstructured":"Geyer CE, Garber JE, Gelber RD, et al. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer. Ann Oncol. 2022 Oct [cited 2022 Nov 27];40. http:\/\/www.annalsofoncology.org\/article\/S0923753422041655\/fulltext","journal-title":"Ann Oncol"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105215"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0310-4"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.16918"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2020.29.10.S6"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-020-00497-x"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1149"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.8430"}],"container-title":["Hospital Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21548331.2023.2266019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T08:15:46Z","timestamp":1707984946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21548331.2023.2266019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,8]]}},"alternative-id":["10.1080\/21548331.2023.2266019"],"URL":"https:\/\/doi.org\/10.1080\/21548331.2023.2266019","relation":{},"ISSN":["2154-8331","2377-1003"],"issn-type":[{"type":"print","value":"2154-8331"},{"type":"electronic","value":"2377-1003"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}